WOAG
WITHDRAWAL OF ATTORNEY GRANTED
13/10/2025
Voltar para busca
Dado oficial do USPTO
PRORELIX RESEARCH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42, 44
Data de depósito
04/05/2022
Data de registro
14/05/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/05/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
04/08/2017
Primeiro uso no comércio
04/08/2017
Código do desenho
3
Tipo de titular
01
Localização do titular
Kad Nagar, Undri Pune,, IN
Examinador
CHISOLM, KEVON
Unidade examinadora
L30
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the word "ProRelix RESEARCH" wherein the word 'Pro' is written in white contained within two green overlapping squares and the word 'Relix' written in dark green color and 'RESEARCH' written in green color to the right of the squares. The grey background is not a feature of the mark.
Titulares e representantes
Titulares
N. A. (pessoa física)
Representantes
Niranjan Narendra Andhalkar
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Clinical research in the field of PharmaBiotechBiopharmaMedical devicesNutraceutical and Herbal domain; Development of pharmaceutical preparations and medicines; Information technology consulting services; Pharmaceutical drug development services; Pharmaceutical research services; Research and development and consultation related thereto in the field of PharmaBiotechBiopharmaMedical devicesNutraceutical and Herbal domain; Research and development in the field of PharmaBiotechBiopharmaMedical devicesNutraceutical and Herbal domain; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of technology in the field of PharmaBiotechBiopharmaMedical devicesNutraceutical and Herbal domain; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Basic and clinical research in the field of respiratory science and medicine; Biochemical research and development; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Consulting in the field of information technology; Laboratory research services relating to pharmaceuticals; Medical and scientific researchconducting clinical trials for others; Outsource service provider in the field of information technology consulting; Outsource service providers in the field of information technology; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of PharmaBiotechBiopharmaMedical devicesNutraceutical and Herbal domain; Testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy
Classe 44
Pharmaceutical compounding services
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
13/10/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
14/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
14/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/03/2024
PUBO
PUBLISHED FOR OPPOSITION
27/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/12/2023
ALIE
ASSIGNED TO LIE
20/12/2023
NREV
NOTICE OF REVIVAL - E-MAILED
25/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/07/2023
PETG
PETITION TO REVIVE-GRANTED
25/07/2023
PROA
TEAS PETITION TO REVIVE RECEIVED
25/07/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/06/2023
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
21/06/2023
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
21/06/2023
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
15/06/2023
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
15/06/2023
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
15/06/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/02/2023
GNRT
NON-FINAL ACTION E-MAILED
23/02/2023
CNRT
NON-FINAL ACTION WRITTEN
23/02/2023
DOCK
ASSIGNED TO EXAMINER
22/02/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/05/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/05/2022
NWAP
NEW APPLICATION ENTERED
07/05/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PRORELIX RESEARCH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.